Discover 1,803 paid clinical trials in Greensboro, North Carolina. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,803
A Study to Evaluate AZD7760 Safety and Pharmacokinetics in Healthy Adults (Phase I) and Adults With End-stage Kidney Disease on Hemodialysis With a Central Venous Catheter (Phase IIa)
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy
for
Breast Cancer, Early Breast Cancer
Location: Winston-Salem NC, Irving TX, Aberdeen SD, Pierre SD
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT05774951
Phase3, Recruiting
Patient Retrospective Outcomes (PRO)
for
Chronic Pain
Location: Winston-Salem NC, New Bern NC, Greenville SC,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT01550575
Recruiting
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
for
Endometrial Cancer
Location: Winston-Salem NC, Charlotte NC, Charlottesville VA,
Sponsor: AstraZeneca
Sex: Female
Age: 18+
Code: NCT06989112
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain
Muscle Fiber Fragment Treatment for Urinary Incontinence
for
Urinary Incontinence
Location: Winston-Salem NC
Sponsor: Wake Forest University
Sex: Female
Age: 18 - 70+
Code: NCT01953263
Phase1, Phase2, Recruiting
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
for
Diabetic Kidney Disease (DKD)
Location: Winston-Salem NC, Greenville NC, New Bern NC,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07271186
Phase2, Recruiting
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney Disease
for
Chronic Kidney Disease
Location: Winston-Salem NC, Morehead City NC, Fleming Island FL,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT06717698
Phase2, Recruiting
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Location: Winston-Salem NC, Cary NC, Wake Forest NC, Hickory NC,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 50 - 70+
Code: NCT06541704
Phase3, Recruiting
Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)
for
Complex Regional Pain Syndrome Type I
Location: Winston-Salem NC, Charlotte NC, Charlottesville VA,
Sponsor: Ambros Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07210515
Phase3, Recruiting
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
for
Non-Small Cell Lung Cancer (NSCLC)
Location: Winston-Salem NC, Charleston WV, Winchester VA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07361510
Phase3, Recruiting
Experimental Round Spermatid Injection (ROSI) to Treat Infertile Couples
A Study to Assess the Effectiveness and Safety of GSK3862995B in Adults With Bronchiectasis
for
Bronchiectasis
Location: Winston-Salem NC, Rock Hill SC, Union SC,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70+
Code: NCT07201051
Phase2, Recruiting
A Study to Investigate Abdominal Symptoms With Camlipixant Compared With Placebo in Adults With Irritable Bowel Syndrome - Diarrhea (IBS-D) and Irritable Bowel Syndrome - Mixed (IBS-M)
for
Irritable Bowel Syndrome
Location: Winston-Salem NC, Salisbury NC, Rocky Mount NC,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70+
Code: NCT07519395
Phase2, Recruiting
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
for
Pulmonary Disease, Chronic Obstructive
Location: Winston-Salem NC, Rock Hill SC, Greenville SC,
Sponsor: GlaxoSmithKline
Sex: All
Age: 40 - 70+
Code: NCT07177339
Phase3, Recruiting
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)